MRN ERN Banner
microRNA as Biomarkers and Diagnostic
4 April, 2016 - 5 April, 2016
Hyatt Regency Cambridge, Cambridge, MA, USA
microRNA as Biomarkers and Diagnostics

Recent research has shown small, non-coding microRNAs to be master regulators of cellular processes, and expression patterns have revealed their potential as diagnostic, prognostic, and treatment response biomarkers. Cambridge Healthtech Institute's Twelfth Annual microRNA as Biomarkers and Diagnostics will cover the latest research in the use of microRNAs for early detection of disease, monitoring cancer progression and therapeutic response, and understanding immunity. Implications for the future of personalized medicine and issues in translating microRNA biomarkers to the clinic will also be discussed.

microRNAs as Non-Invasive Diagnostic and Predictive Biomarkers

Noncoding RNA Biomarkers in Colorectal Cancer

Ajay Goel, Ph.D., Professor and Director, Center for Gastrointestinal Research, and Director, Center for Epigenetics, Cancer Prevention & Cancer Genomics, Baylor Research Institute, Baylor University Medical Center

Non-Invasive miRNA Biomarkers for Kidney Disease

Vishal S. Vaidya, Ph.D., Associate Professor, Medicine & Environmental Health, Harvard Medical School, Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital

Circulating microRNAs in Cardiac Disease and Dysfunction

Yuri D'Alessandra, Ph.D., Senior Researcher, Immunology and Functional Genomics Unit, Centro Cardiologico Monzino

Identifying microRNA Biomarkers in Tissue and Biofluids

Gender-Specific, Population-Specific, and Race-Specific Regulatory Non-Coding RNAs

Isidore Rigoutsos, Ph.D., Professor and Director, Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University

Identification of microRNA Signatures Predicting Survival and Treatment Response in Glioblastoma

Sean Lawler, Ph.D., Assistant Professor, Neurosurgery, Brigham & Women's Hospital, Harvard Medical School

MicroRNA Signatures in Renal Disease: A Meta-Analysis of Tissue and Urine Datasets

Christos Argyropoulos, M.D., MS, Ph.D., Assistant Professor, Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine

microRNAs in Drug Development

Identification of Urinary microRNA Biomarkers of Glomerular Injury

Rounak Nassirpour, Ph.D., Principal Scientist, Biomarkers Laboratory, Drug Safety R&D, Pfizer

Evaluation of Noninvasive microRNAs as Biomarkers of Injury for Drug Safety

Xi Yang, Ph.D., Research Biologist, Systems Biology, National Center for Toxicological Research, FDA

Use of microRNAs to Understand Differential Signaling between Lung Tumor Subtypes and Predict Therapeutic Response

Molly A. Taylor, Ph.D., Senior Scientist, AstraZeneca

Cell-Free Circulating microRNAs as a Reflection of Liver Disease

Steven Lockton, Ph.D., Senior Scientist, microMarkers, Regulus Therapeutics

Role of microRNAs in Cancer Pathways

Predictive and Functional Roles of miRNA in Metastatic Melanoma

Eva Hernando, Ph.D., Associate Professor and Vice Chair for Science, Department of Pathology; Co-Leader, Melanoma Program, NYU Langone Medical Center

microRNA Biogenesis Pathways in Cancer

Richard I. Gregory, Ph.D., Associate Professor, Department of Biological Chemistry and Molecular Pharmacology, Department of Pediatrics, Harvard Medical School, Harvard Stem Cell Institute, The Stem Cell Program at Boston Children's Hospital

Elimination of Colon Cancer Stem Cells by miR-140 through SMAD2 and Autophagy

Jingfang Ju, Ph.D., Associate Professor and Co-Director, Translational Research, Pathology, Stony Brook University

Challenges of NGS

Discovery of New Blood-Borne miRNAs in Human Pathologies by NGS

Andreas Keller, Ph.D., Chair and Professor, Clinical Bioinformatics, University Hospital, Saarland University

* The program is subject to change without notice, due to unforeseen reason.

View Media Partners


Industry Event Calendar
Search for Pharmaceuticals

CHI | Cambridge HealthTech Institute
Global Information, Inc. - International Marketing Partner of Cambridge HealthTech Institute